Nina Bhardwaj, MD, PhD
Director of Immunotherapy; Medical Director, Vaccine and Cell Therapy Laboratory; Co-Director, Cancer Immunology Program
Icahn School of Medicine at Mount Sinai
Nina Bhardwaj MD, PhD, is Professor of Medicine and Urology and Director of Immunotherapy at The Tisch Cancer Institute. She also serves as Medical Director of the Vaccine and Cell Therapy Laboratory, Co-Director of the Cancer Immunology Program, and a faculty member of the Icahn Genomics Institute, holding the Ward Coleman Chair in Cancer Research.
Dr. Bhardwaj is a leader in dendritic cell biology, advancing understanding of their immunology and use in vaccines. She has developed Toll-like receptor agonist and dendritic cell–based vaccines for cancer and infectious diseases, and has pioneered neoantigen vaccine research. Her work translates basic science into clinical trials.
Dr. Bhardwaj is a leader in dendritic cell biology, advancing understanding of their immunology and use in vaccines. She has developed Toll-like receptor agonist and dendritic cell–based vaccines for cancer and infectious diseases, and has pioneered neoantigen vaccine research. Her work translates basic science into clinical trials.
